Who Discovered Hemophilia?

Marked by the human body’s inability to stop coagulation or blood clotting, hemophilia is a serious disease affecting numerous individuals all over the world. This condition refers to a set of hereditary genetic disorders. Aside from the possible causes, symptoms and treatments for this medical condition, it is also interesting to know its history including who discovered hemophilia.

The Discovery of Hemophilia

Who discovered hemophilia? A physician from Philadelphia in Pennsylvania named John Conrad Otto was the very first to discover this genetic disorder in 1803. He described the condition as hereditary, which affected males more compared to females. He then tried to track the source of the disease, who then found his way to a woman who lived in Plymouth some time in 1720. In 1828, the term ‘hemophilia’ was first used at the University of Zurich in Switzerland.

Additional Facts and Other Important Information

This disease was prominent in European royalty, the main reason why it is referred to as the royal disease. Some of the notable individuals who suffered from this medical condition were Tsarevich Alexei Nikolaevich and Queen Victoria. Based on reports, hemophilia is truly a complicated disease because there are lots of complications involved from its treatment as well as from the disease itself.

One of the known complications of this disease is called deep internal bleeding, which is actually bleeding of deep muscles leading to pain, numbness and swelling of a limb. Another major complication is intracranial hemorrhage, which is marked by the pressure buildup in the skull. Proper care is important under this condition because it can lead to brain damage, loss of consciousness and even death. Other complications include adverse reactions, transfusion transmitted infection and joint damage.

Until now, medical science has yet to provide a cure for this condition. However, it is very much possible to infuse patients regularly with deficient clotting factor. The United States Food and Drug Administration approved the anti-hemophilic factor Xyntha in the early parts of 2008.

Patients are usually advised to perform different kinds of preventative exercises. The purpose of these activities is to strengthen their joints, specifically in the ankles, knees and elbows. Such exercises are performed not only to strengthen the muscles of patients, but also to tone and increase their flexibility. Examples of these highly recommended exercises are quadriceps sets, elbow flexions and stretching of the calves. Likewise, it is also good for patients to perform ankle circles as well as basic sports warm-up exercises.

Related Posts